Macy's, Oracle and 3 Stocks to Watch Heading Into Thursday

Cooper Companies fell 16% after reporting Q3 EPS of $1.15 versus $1.12 consensus but missing sales expectations at $1.066B versus $1.098B and cutting FY26 guidance below estimates. American Eagle posted upbeat fiscal Q2 results aided by a large tariff refund and forecast mid-single-digit comparable-sales growth for Q3 and FY26, yet shares dropped 10.6%. Macy's, Adobe and Oracle are due to report, with consensus estimates of $0.37/$4.83B, $6.09/$6.69B and $1.74/$19.14B for EPS/revenue, respectively.

Analysis

COO’s guide-down is more consequential than the quarterly EPS beat because it resets the earnings-power debate in a premium-multiple medtech name. The key question is whether the shortfall reflects temporary timing in Surgical/CooperSurgical or slower underlying demand in contact lenses and fertility; the former supports a gap-fill, while the latter invites a multi-quarter estimate reset and relative underperformance versus ALGN, XRAY and resilient large-cap medtech. The 16% after-hours move likely prices a material cut, but not necessarily a second reduction if management’s revised assumptions prove optimistic.

AEO’s apparent earnings strength should not be extrapolated mechanically: a tariff refund is non-recurring, and the stock’s negative reaction despite constructive comparable-sales commentary indicates investors are focused on the durability of gross-margin recovery after the benefit rolls off. Its sales outlook is a more useful near-term read-through for youth apparel demand than Macy’s results, but AEO’s inventory, markdown rate and freight/tariff exposure will determine whether revenue growth converts to earnings. A clean margin guide would be supportive for ANF and URBN; incremental promotional activity would instead reinforce a short bias in department-store and lower-end discretionary retail.

For ADBE and ORCL, headline EPS is secondary to forward indicators. Adobe must show that AI product adoption is converting into net-new ARR rather than cannibalizing its existing creative-seat base; weak remaining-performance-obligation or digital-media net-new ARR commentary would pressure the multiple regardless of a modest beat. Oracle’s valuation now requires cloud infrastructure growth, capacity availability and contract backlog conversion to remain exceptionally strong; any evidence that power, data-center buildouts or customer implementation timing is delaying revenue recognition would create a more attractive short-term downside catalyst than a consensus EPS miss.

Key Decisions for Investors

• Treat COO as a 1-3 month short/watch rather than chase the opening gap: initiate only if it fails to reclaim the post-earnings VWAP after management clarifies segment assumptions. Target further estimate-reset downside; cover if revised FY26 guidance is reaffirmed next quarter and organic contact-lens volumes reaccelerate.
• Pair long AEO / short M over the next earnings cycle only if AEO confirms mid-single-digit comparable-sales growth excluding the tariff benefit and holds gross margin. The trade expresses relative brand relevance and balance-sheet flexibility; exit if AEO raises markdown guidance or Macy’s demonstrates sustained comparable-sales and inventory improvement.
• For ADBE, wait for the release and use a 1-3 day post-earnings reaction: buy only if management raises full-year ARR/revenue expectations with AI monetization evidence, not merely cost control. A weaker ARR outlook or elevated churn would favor a tactical short versus IGV, with the thesis invalidated by accelerating paid AI attach rates.
• Maintain ORCL as an event-driven long only through a defined-risk structure, such as a 1-2 month call spread, contingent on disclosed cloud backlog and infrastructure growth exceeding current expectations. Do not add on a headline EPS beat if revenue conversion is deferred; a slowdown in cloud growth or commentary on capacity constraints is the catalyst to close longs or tactically short versus MSFT.